Skip to main content

Perspective Therapeutics, Inc.

For the period ended Sep 30, 2025. Filed Nov 10, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 10, 2025

CATX$0.84+6.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I · FINANCIAL INFORMATION
Item 1Financial Statements1
Condensed Consolidated Balance Sheets as of September 30, 2025 (unaudited) and December 31, 20241
Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2025 and 2024 (unaudited)2
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (unaudited)3
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2025 and 2024 (unaudited)4
Notes to the Unaudited Condensed Consolidated Financial Statements6
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations19
Item 3Quantitative and Qualitative Disclosures About Market Risk30
Item 4Controls and Procedures30
PART IIOTHER INFORMATION
Item 1Legal Proceedings31
Item 1ARisk Factors31
Item 2Unregistered Sales of Equity Securities and Use of Proceeds31
Item 3Defaults Upon Senior Securities31
Item 4Mine Safety Disclosures31
Item 5Other Information31
Item 6Exhibits32
Signatures33

iii

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.